TET2 and myeloid sarcoma: In addition, the inv(16) translocation and mutations in the RAS pathway, DNMT3A, NPM1, IDH2, JAK2, KRAS, PTPN11, TET2, BCOR, and RAD21 have been found in MS patients [28].